Literature DB >> 24332449

Reduced excitatory amino acid transporter 1 and metabotropic glutamate receptor 5 expression in the cerebellum of fragile X mental retardation gene 1 premutation carriers with fragile X-associated tremor/ataxia syndrome.

Dalyir I Pretto1, Madhur Kumar2, Zhengyu Cao3, Christopher L Cunningham4, Blythe Durbin-Johnson5, Lihong Qi5, Robert Berman6, Stephen C Noctor7, Randi J Hagerman8, Isaac N Pessah9, Flora Tassone10.   

Abstract

A premutation (PM) expansion (55-200 CGG) in the fragile X mental retardation gene 1 causes elevated messenger RNA and reduced fragile X mental retardation gene 1 protein. Young PM carriers can develop characteristic physical features and mild cognitive disabilities. In addition, individuals with PM, particularly male carriers, are at high risk to develop fragile X-associated tremor/ataxia syndrome (FXTAS) with aging. Human postmortem FXTAS brains show extensive white matter disease in the cerebellum and the presence of intranuclear inclusions throughout the brain, although their etiologic significance is unknown. In the current work, expression levels of the metabotropic glutamate (Glu) receptor 5 and the Glu transporter excitatory amino acid transporter 1, examined by reverse transcription polymerase chain reaction and western blot analyses, were found to be reduced in the postmortem cerebellum of PM carriers with FXTAS compared with age matched controls, with higher CGG repeat number having greater reductions in both proteins. These data suggests a dysregulation of Glu signaling in PM carriers, which would likely contribute to the development and severity of FXTAS.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  EAAT1; EAAT2; FMR1; FMRP; FXTAS; Fragile X tremor/ataxia syndrome; Glu transporters; Premutation; mGluR5

Mesh:

Substances:

Year:  2013        PMID: 24332449      PMCID: PMC4062976          DOI: 10.1016/j.neurobiolaging.2013.11.009

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  60 in total

1.  Intranuclear inclusions in neural cells with premutation alleles in fragile X associated tremor/ataxia syndrome.

Authors:  F Tassone; R J Hagerman; D Garcia-Arocena; E W Khandjian; C M Greco; P J Hagerman
Journal:  J Med Genet       Date:  2004-04       Impact factor: 6.318

Review 2.  Translating glutamate: from pathophysiology to treatment.

Authors:  Daniel C Javitt; Darryle Schoepp; Peter W Kalivas; Nora D Volkow; Carlos Zarate; Kalpana Merchant; Mark F Bear; Daniel Umbricht; Mihaly Hajos; William Z Potter; Chi-Ming Lee
Journal:  Sci Transl Med       Date:  2011-09-28       Impact factor: 17.956

3.  Abnormal dendrite and spine morphology in primary visual cortex in the CGG knock-in mouse model of the fragile X premutation.

Authors:  Robert F Berman; Karl D Murray; Gloria Arque; Michael R Hunsaker; H Jürgen Wenzel
Journal:  Epilepsia       Date:  2012-06       Impact factor: 5.864

4.  Lifting the mood on treating fragile X.

Authors:  Emily K Osterweil; Peter C Kind; Mark F Bear
Journal:  Biol Psychiatry       Date:  2012-12-01       Impact factor: 13.382

5.  Expression cloning of a rat glutamate transporter.

Authors:  K Tanaka
Journal:  Neurosci Res       Date:  1993-02       Impact factor: 3.304

6.  Sam68 sequestration and partial loss of function are associated with splicing alterations in FXTAS patients.

Authors:  Chantal Sellier; Frédérique Rau; Yilei Liu; Flora Tassone; Renate K Hukema; Renata Gattoni; Anne Schneider; Stéphane Richard; Rob Willemsen; David J Elliott; Paul J Hagerman; Nicolas Charlet-Berguerand
Journal:  EMBO J       Date:  2010-02-25       Impact factor: 11.598

Review 7.  Glutamate uptake.

Authors:  N C Danbolt
Journal:  Prog Neurobiol       Date:  2001-09       Impact factor: 11.685

8.  Impaired activity-dependent FMRP translation and enhanced mGluR-dependent LTD in Fragile X premutation mice.

Authors:  Adam J Iliff; Abigail J Renoux; Amy Krans; Karen Usdin; Michael A Sutton; Peter K Todd
Journal:  Hum Mol Genet       Date:  2012-12-18       Impact factor: 6.150

Review 9.  Treatment of fragile X-associated tremor ataxia syndrome (FXTAS) and related neurological problems.

Authors:  Randi J Hagerman; Deborah A Hall; Sarah Coffey; Maureen Leehey; James Bourgeois; John Gould; Lin Zhang; Andreea Seritan; Elizabeth Berry-Kravis; John Olichney; Joshua W Miller; Amy L Fong; Randall Carpenter; Cathy Bodine; Louise W Gane; Edgar Rainin; Hillary Hagerman; Paul J Hagerman
Journal:  Clin Interv Aging       Date:  2008       Impact factor: 4.458

10.  FMR1 CGG allele size and prevalence ascertained through newborn screening in the United States.

Authors:  Flora Tassone; Ka Pou Iong; Tzu-Han Tong; Joyce Lo; Louise W Gane; Elizabeth Berry-Kravis; Danh Nguyen; Lisa Y Mu; Jennifer Laffin; Don B Bailey; Randi J Hagerman
Journal:  Genome Med       Date:  2012-12-21       Impact factor: 11.117

View more
  19 in total

1.  Acute Ethanol Produces Ataxia and Induces Fmr1 Expression via Histone Modifications in the Rat Cerebellum.

Authors:  Russell S Dulman; James Auta; Tara Teppen; Subhash C Pandey
Journal:  Alcohol Clin Exp Res       Date:  2019-05-14       Impact factor: 3.455

2.  Conditional Knock-out of mGluR5 from Astrocytes during Epilepsy Development Impairs High-Frequency Glutamate Uptake.

Authors:  Anthony D Umpierre; Peter J West; John A White; Karen S Wilcox
Journal:  J Neurosci       Date:  2018-11-30       Impact factor: 6.167

Review 3.  GABA receptor subunit distribution and FMRP-mGluR5 signaling abnormalities in the cerebellum of subjects with schizophrenia, mood disorders, and autism.

Authors:  S Hossein Fatemi; Timothy D Folsom
Journal:  Schizophr Res       Date:  2014-11-26       Impact factor: 4.939

4.  Calcium dysregulation and Cdk5-ATM pathway involved in a mouse model of fragile X-associated tremor/ataxia syndrome.

Authors:  Gaëlle Robin; José R López; Glenda M Espinal; Susan Hulsizer; Paul J Hagerman; Isaac N Pessah
Journal:  Hum Mol Genet       Date:  2017-07-15       Impact factor: 6.150

5.  Differential increases of specific FMR1 mRNA isoforms in premutation carriers.

Authors:  Dalyir I Pretto; John S Eid; Carolyn M Yrigollen; Hiu-Tung Tang; Erick W Loomis; Chris Raske; Blythe Durbin-Johnson; Paul J Hagerman; Flora Tassone
Journal:  J Med Genet       Date:  2014-10-30       Impact factor: 6.318

6.  Persistence of cerebellar ataxia during chronic ethanol exposure is associated with epigenetic up-regulation of Fmr1 gene expression in rat cerebellum.

Authors:  Russell S Dulman; James Auta; Gabriela M Wandling; Ryan Patwell; Huaibo Zhang; Subhash C Pandey
Journal:  Alcohol Clin Exp Res       Date:  2021-08-28       Impact factor: 3.928

7.  Impaired sensorimotor gating in Fmr1 knock out and Fragile X premutation model mice.

Authors:  A J Renoux; K J Sala-Hamrick; N M Carducci; M Frazer; K E Halsey; M A Sutton; D F Dolan; G G Murphy; P K Todd
Journal:  Behav Brain Res       Date:  2014-03-19       Impact factor: 3.332

Review 8.  Metabotropic glutamate receptor 5 - a promising target in drug development and neuroimaging.

Authors:  Rajapillai L I Pillai; Dnyanesh N Tipre
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-01-07       Impact factor: 9.236

9.  Fragile X mental retardation protein expression in Alzheimer's disease.

Authors:  Abigail J Renoux; Nicholas M Carducci; Arya A Ahmady; Peter K Todd
Journal:  Front Genet       Date:  2014-10-21       Impact factor: 4.599

Review 10.  Mouse models of the fragile X premutation and fragile X-associated tremor/ataxia syndrome.

Authors:  Robert F Berman; Ronald Am Buijsen; Karen Usdin; Elizabeth Pintado; Frank Kooy; Dalyir Pretto; Isaac N Pessah; David L Nelson; Zachary Zalewski; Nicholas Charlet-Bergeurand; Rob Willemsen; Renate K Hukema
Journal:  J Neurodev Disord       Date:  2014-07-30       Impact factor: 4.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.